Literature DB >> 17121317

Myoinositol/folic acid combination for the treatment of erectile dysfunction in type 2 diabetes men: a double-blind, randomized, placebo-controlled study.

R Agostini1, F Rossi, R Pajalich.   

Abstract

Erectile dysfunction is a common complication of diabetes. Diabetes can cause neuropathy or damage to nerves throughout your body, including the penis. Damaged nerves can't communicate properly. So even though you might be emotionally stimulated to have intercourse, nerve damage means that information isn't relayed to the penis, and it doesn't respond. In addition, poor blood sugar control can inhibit nitric oxide production. Lack of nitric oxide can prevent the pressure of blood in the corpora cavernosa from rising enough to close off penile veins, allowing blood to flow out of the penis instead of remaining trapped for an erection. This prospective, randomized, double-blind, placebo-controlled study included 176 patients with type 2 diabetes. The daily 4 g dose of inositol plus 400 microg of folic acid or placebo was divided and given in three doses. The present study demonstrates that Myoinositol/folic acid combination, deserves consideration as therapeutic agent for preventing and treating erectile dysfunction in diabetic men, probably by virtue of both their chronic metabolic, acute ROS scavenging, and NO protective beneficial effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17121317

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

1.  Sexual dysfunctions in patients with diabetes: a study from Iran.

Authors:  Marzieh Ziaei-Rad; Mariam Vahdaninia; Ali Montazeri
Journal:  Reprod Biol Endocrinol       Date:  2010-05-18       Impact factor: 5.211

Review 2.  Serum Folic Acid and Erectile Dysfunction: A Systematic Review and Meta-Analysis.

Authors:  Yuyang Zhang; Wei Zhang; Yutian Dai; Hui Jiang; Xiansheng Zhang
Journal:  Sex Med       Date:  2021-05-26       Impact factor: 2.491

3.  The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes.

Authors:  Basilio Pintaudi; Giacoma Di Vieste; Matteo Bonomo
Journal:  Int J Endocrinol       Date:  2016-10-11       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.